Christophe Beauduin

Special Counsel

Christophe Beauduin is a Special Counsel in the firm’s New York office where he focuses on advising a wide variety of life sciences companies researching, discovering, developing and marketing products in various therapeutic areas and across all stages of development. Christophe works closely with his clients in connection with their overall licensing and partnering strategy, and assists them in the structuring, drafting, and negotiating of complex strategic business development transactions, including research and discovery relationships, clinical product collaborations and commercial stage agreements.

Download full bio 


  • CinCor Pharma to Sell to AstraZeneca for Approximately $1.8 Billion 

  • Scorpion Therapeutics Enters Collaboration Agreement with AstraZeneca 

  • Nykode Therapeutics Enters Collaboration Agreement with Regeneron 


  • Northwestern University Pritzker School of Law
    LLM, with honors, 2003

  • Université Catholique de Louvain
    Licence en droit, magna cum laude, 2001

  • Université de Namur
    Candidature en droit, 1998

Admissions & Credentials

New York